Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Corren

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 12, 2022
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR studyJonathan Corren, Christopher S Ambrose, Janet M Griffiths, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 4, 2017
Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthmaBradley E Chipps, Jonathan Corren, Elliot Israel, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2020
ReplyPhilippe Gevaert, Jonathan Corren, Joaquim Mullol, et al.
Allergy|October 3, 2020
Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baselineArnaud Bourdin, Alberto A Papi, Jonathan Corren, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 14, 2022
Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthmaJonathan Corren, Michael E Wechsler, Geoffrey Chupp, et al.
Clinical Therapeutics|July 28, 2018
Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With OmalizumabXuehua Ke, Abhishek Kavati, Debra Wertz, et al.
Annals of the American Thoracic Society|April 23, 2021
A Comprehensive Analysis of the Stability of Blood Eosinophil LevelsBradley E Chipps, Nizar Jarjour, William J Calhoun, et al.
ERJ Open Research|October 4, 2019
Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE TrialAndrew Menzies-Gow, Jonathan Corren, Elisabeth H Bel, et al.
American Journal of Respiratory and Critical Care Medicine|March 26, 2010
Meeting the obligation to balance bioethics and clinical trial design in asthmaEugene R Bleecker, Harold S Nelson, Monica Kraft, et al.
American Journal of Respiratory and Critical Care Medicine|November 14, 2009
Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionateEugene R Bleecker, Harold S Nelson, Monica Kraft, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 12, 2022
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR studyJonathan Corren, Christopher S Ambrose, Janet M Griffiths, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 4, 2017
Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthmaBradley E Chipps, Jonathan Corren, Elliot Israel, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2020
ReplyPhilippe Gevaert, Jonathan Corren, Joaquim Mullol, et al.
Allergy|October 3, 2020
Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baselineArnaud Bourdin, Alberto A Papi, Jonathan Corren, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 14, 2022
Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthmaJonathan Corren, Michael E Wechsler, Geoffrey Chupp, et al.
Clinical Therapeutics|July 28, 2018
Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With OmalizumabXuehua Ke, Abhishek Kavati, Debra Wertz, et al.
Annals of the American Thoracic Society|April 23, 2021
A Comprehensive Analysis of the Stability of Blood Eosinophil LevelsBradley E Chipps, Nizar Jarjour, William J Calhoun, et al.
ERJ Open Research|October 4, 2019
Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE TrialAndrew Menzies-Gow, Jonathan Corren, Elisabeth H Bel, et al.
American Journal of Respiratory and Critical Care Medicine|March 26, 2010
Meeting the obligation to balance bioethics and clinical trial design in asthmaEugene R Bleecker, Harold S Nelson, Monica Kraft, et al.
American Journal of Respiratory and Critical Care Medicine|November 14, 2009
Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionateEugene R Bleecker, Harold S Nelson, Monica Kraft, et al.
Pageof 15